Year joined: 2014
Qualifications: MBiochem DPhil EPA CPA
James handles a mix of EPO prosecution and opposition work in the life sciences sector.¬† He has particular expertise in immunology, including antibody-based therapeutics and vaccines, diagnostics, nucleic acid amplification, (oligo) nucleotide therapy, gene editing and plant extracts.¬† He is experienced in handling EPO opposition proceedings and regularly appears before EPO tribunals on behalf of clients.¬† James also has extensive experience with supplementary protection certificates.¬† He has co-ordinated prosecution of several SPC/paediatric extension portfolios across Europe, and regularly advises clients in this area, including in relation to SPC disputes.
James has a master's degree in biochemistry and a doctorate on the biochemistry of heart disease, both from Oxford University. James also conducted post-doctoral research at Universit√© Paris-XI on cardiac disease. He is an author of several peer-reviewed papers on this subject.
Membership & Organisations
James is a CIPA fellow and member of the EPI.
Representation of opponent at oral proceedings in the widely-reported CRISPR-Cas9 case in which the EPO ordered revocation of EP-B-2771468 belonging to the Broad Institute, et al. (January 2018).¬†¬†¬† ¬†¬†